Status:

COMPLETED

The Oral Iron on the Prevention of Iron Deficiency Anemia in Obese Pregnant

Lead Sponsor:

Assiut University

Conditions:

Anemia of Pregnancy

Eligibility:

FEMALE

20-35 years

Phase:

NA

Brief Summary

Anemia is known as a condition in which the hemoglobin level is lower than normal. Anemia is one of the most common complications during pregnancy. Anemia in pregnancy is defined as a hemoglobin level...

Eligibility Criteria

Inclusion

  • Pregnant woman in a singleton pregnancy (12-14 weeks).
  • BMI (30- 40 kg/m2).
  • Normal hemoglobin level (\>11 g/dL).
  • Normal hematocrit (Hct 31-41%).
  • Normal ferritin level (6-130 ng/mL).
  • Women willingness to participate in the study.
  • Women living in the nearby area to make follow-up visits possible.

Exclusion

  • Multiple gestations.
  • Women received a recent blood transfusion.
  • Women with threatened miscarriage.
  • Women are known to have pathological blood loss.
  • Intolerant to oral iron form.
  • History of the hematologic disorder.
  • Women used iron in the past 3 months.
  • Women with chronic diseases (hypertension, diabetes, renal diseases, thyroid disease……).

Key Trial Info

Start Date :

October 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2022

Estimated Enrollment :

230 Patients enrolled

Trial Details

Trial ID

NCT04101461

Start Date

October 1 2019

End Date

April 1 2022

Last Update

May 4 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Woman's Health Hospital - Assiut university

Asyut, Egypt, 71111